Resectable Glioblastoma Clinical Trials in Los Angeles, California
2 recruitingLos Angeles, California
Showing 1–2 of 2 trials
Recruiting
Phase 1
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
Resectable GlioblastomaIDH Wildtype GlioblastomaRecurrent Astrocytoma+2 more
Jonsson Comprehensive Cancer Center10 enrolled1 locationNCT07089641
Recruiting
Not Applicable
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
GlioblastomaRecurrent GlioblastomaResectable Glioblastoma
Jonsson Comprehensive Cancer Center50 enrolled1 locationNCT06090903